World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 4423987

Number of visits today: 4032

Number of downloads: 4060642

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Klämbt V, Gimpel C, Bald M, Gerken C, Billing H, Loos S, Hansen M, König J, Vinke T, Montoya C, Lange-Sperandio B, Kirschstein M, Hennies I, Pohl M, Häffner K. Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis. Pediatr Nephrol 2021;36:463-71. [PMID: 32715379 DOI: 10.1007/s00467-020-04714-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]

For:

Klämbt V, Gimpel C, Bald M, Gerken C, Billing H, Loos S, Hansen M, König J, Vinke T, Montoya C, Lange-Sperandio B, Kirschstein M, Hennies I, Pohl M, Häffner K. Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis. Pediatr Nephrol 2021;36:463-71. [PMID: 32715379 DOI: 10.1007/s00467-020-04714-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]

Number	Citing Articles
1	de Souza RM, Correa BHM, Melo PHM, Pousa PA, de Mendonça TSC, Rodrigues LGC, Simões E Silva AC. The treatment of atypical hemolytic uremic syndrome with eculizumab in pediatric patients: a systematic review. Pediatr Nephrol 2023;38:61-75. [PMID: 35864223 DOI: 10.1007/s00467-022-05683-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2	Boyer O, Niaudet P. Hemolytic-Uremic Syndrome in Children. Pediatr Clin North Am 2022;69:1181-97. [PMID: 36880929 DOI: 10.1016/j.pcl.2022.07.006] [Reference Citation Analysis]
3	Smarz-Widelska I, Syroka-Główka M, Janowska-Jaremek J, Kozioł MM, Załuska W. Atypical Hemolytic Uremic Syndrome after SARS-CoV-2 Infection: Report of Two Cases. Int J Environ Res Public Health 2022;19. [PMID: 36141710 DOI: 10.3390/ijerph191811437] [Reference Citation Analysis]
4	Acosta-Medina AA, Moyer AM, Go RS, Willrich MAV, Fervenza FC, Leung N, Bourlon C, Winters JL, Spears GM, Bryant SC, Sridharan M. Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation. Blood Adv 2023;7:340-50. [PMID: 35533258 DOI: 10.1182/bloodadvances.2021006416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5	Wiesener MS. Wie lange sollte aHUS behandelt werden? Nephrologe 2021;16:395-396. [DOI: 10.1007/s11560-021-00522-1] [Reference Citation Analysis]